v3.25.2
Unaudited Interim Consolidated Statement Equity - USD ($)
$ in Millions
Total
Common Stock
Treasury Stock, Common
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss), Net
Balance as of the beginning of the period (in shares) at Dec. 31, 2023     61,570,314      
Balance as of the beginning of the period (in shares) at Dec. 31, 2023   108,906,426        
Balance as of the beginning of the period at Dec. 31, 2023   $ 0 $ (5,488) $ 394 $ 12,909 $ (744)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises, shares   9,239        
Stock option exercises   $ 0   1    
Stock awards (in shares)   346,898        
Stock awards   $ 0        
Issuance of treasury stock under stock plans (in shares)     (33,068)      
Issuance of treasury stock under stock plans     $ 1      
Stock-based compensation, net of tax       (1)    
Net earnings (loss) attributable to Celanese Corporation $ 276       276  
Common stock dividends         (154)  
Other comprehensive income (loss), net of tax (48)         (48)
Balance as of the end of the period (in shares) at Jun. 30, 2024   109,262,563        
Balance as of the end of the period at Jun. 30, 2024 7,146 $ 0 $ (5,487) 394 13,031 (792)
Balance as of the end of the period (in shares) at Jun. 30, 2024     61,537,246      
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2023 461          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to noncontrolling interests 1          
Other comprehensive income (loss), net of tax (1)          
Distributions/dividends to noncontrolling interests (18)          
Balance as of the end of the period, noncontrolling interest at Jun. 30, 2024 443          
Balance as of the beginning of the period (in shares) at Mar. 31, 2024     61,570,314      
Balance as of the beginning of the period (in shares) at Mar. 31, 2024   109,210,286        
Balance as of the beginning of the period at Mar. 31, 2024   $ 0 $ (5,488) 383 12,953 (797)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises, shares   1,292        
Stock option exercises   $ 0        
Stock awards (in shares)   50,985        
Stock awards   $ 0        
Issuance of treasury stock under stock plans (in shares)     (33,068)      
Issuance of treasury stock under stock plans     $ 1      
Stock-based compensation, net of tax       11    
Net earnings (loss) attributable to Celanese Corporation 155       155  
Common stock dividends         (77)  
Other comprehensive income (loss), net of tax 5         5
Balance as of the end of the period (in shares) at Jun. 30, 2024   109,262,563        
Balance as of the end of the period at Jun. 30, 2024 7,146 $ 0 $ (5,487) 394 13,031 (792)
Balance as of the end of the period (in shares) at Jun. 30, 2024     61,537,246      
Balance as of the beginning of the period, noncontrolling interest at Mar. 31, 2024 460          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to noncontrolling interests (2)          
Other comprehensive income (loss), net of tax (1)          
Distributions/dividends to noncontrolling interests (14)          
Balance as of the end of the period, noncontrolling interest at Jun. 30, 2024 443          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total equity 7,589          
Total equity $ 5,580         (848)
Balance as of the beginning of the period (in shares) at Dec. 31, 2024 61,499,640   61,499,640      
Balance as of the beginning of the period (in shares) at Dec. 31, 2024   109,327,556        
Balance as of the beginning of the period at Dec. 31, 2024 $ 5,146 $ 0 $ (5,486) 409 11,071 (848)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises, shares   0        
Stock option exercises   $ 0   0    
Stock awards (in shares)   174,320        
Stock awards   $ 0        
Issuance of treasury stock under stock plans (in shares)     (87,055)      
Issuance of treasury stock under stock plans     $ 3      
Stock-based compensation, net of tax       10    
Net earnings (loss) attributable to Celanese Corporation 178       178  
Common stock dividends         (6)  
Other comprehensive income (loss), net of tax (55)         (55)
Balance as of the end of the period (in shares) at Jun. 30, 2025   109,501,876        
Balance as of the end of the period at Jun. 30, 2025 $ 5,276 $ 0 $ (5,483) 419 11,243 (903)
Balance as of the end of the period (in shares) at Jun. 30, 2025 61,412,585   61,412,585      
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2024 $ 434          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to noncontrolling interests 7          
Other comprehensive income (loss), net of tax 1          
Distributions/dividends to noncontrolling interests (14)          
Balance as of the end of the period, noncontrolling interest at Jun. 30, 2025 428          
Balance as of the beginning of the period (in shares) at Mar. 31, 2025     61,499,640      
Balance as of the beginning of the period (in shares) at Mar. 31, 2025   109,403,403        
Balance as of the beginning of the period at Mar. 31, 2025   $ 0 $ (5,486) 413 11,047 (817)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises, shares   0        
Stock option exercises   $ 0        
Stock awards (in shares)   98,473        
Stock awards   $ 0        
Issuance of treasury stock under stock plans (in shares)     (87,055)      
Issuance of treasury stock under stock plans     $ 3      
Stock-based compensation, net of tax       6    
Net earnings (loss) attributable to Celanese Corporation 199       199  
Common stock dividends         (3)  
Other comprehensive income (loss), net of tax (86)         (86)
Balance as of the end of the period (in shares) at Jun. 30, 2025   109,501,876        
Balance as of the end of the period at Jun. 30, 2025 $ 5,276 $ 0 $ (5,483) $ 419 $ 11,243 (903)
Balance as of the end of the period (in shares) at Jun. 30, 2025 61,412,585   61,412,585      
Balance as of the beginning of the period, noncontrolling interest at Mar. 31, 2025 $ 429          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to noncontrolling interests 3          
Other comprehensive income (loss), net of tax 1          
Distributions/dividends to noncontrolling interests (5)          
Balance as of the end of the period, noncontrolling interest at Jun. 30, 2025 428          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Total equity $ 5,704         $ (903)